This change to your skin can be a sign you have one of the deadliest cancers
About 67,400 Americans will be diagnosed with pancreatic cancer this year, and nearly 52,000 will die from it, according to American Cancer Society estimates.
The highly aggressive disease develops from abnormal cell growth within the pancreas, a vital organ that plays a crucial role in digestion and blood sugar regulation.
Advertisement
4 Dr. Diane Simeone is the founding director of the Pancreatic Cancer Early Detection (PRECEDE) Consortium, which aims to increase the five-year pancreatic cancer survival rate from 13% to 50%.
Courtesy of the PRECEDE Consortium
It's one of the deadliest cancers — only 13% of pancreatic cancer patients typically survive five years after diagnosis — because early detection is so difficult.
'The pancreas is hidden deep in the abdomen, and early symptoms, such as back pain, fatigue, weight loss or digestive discomfort, are vague and often mistaken for other, less serious conditions,' Dr. Diane Simeone, director of Moores Cancer Center at UC San Diego Health, told The Post.
Jaundice — the yellowing of the skin and the whites of the eyes — is a clearer sign of pancreatic cancer. Simeone highlights why many patients get this sneaky symptom — and why screening is so important.
Advertisement
What is jaundice?
Jaundice occurs when the blood has excess bilirubin, a yellowish substance that's produced when the body breaks down old red blood cells.
The liver is most responsible for eliminating bilirubin.
4 Jaundice — the yellowing of the skin and the whites of the eyes — is a visible sign of pancreatic cancer.
New Africa – stock.adobe.com
Advertisement
A tumor blocking the bile ducts or affecting the liver's function can prevent the proper processing of bilirubin, causing the pigment to accumulate.
The yellowing of the whites of the eyes is often the first noticeable sign — the skin and the inside of the mouth may turn yellow as well.
Jaundice can also cause dark urine, pale poop and sometimes itchy skin and stomach pain.
Advertisement
'The excess bilirubin is excreted through the kidneys, darkening the urine and preventing it from reaching the intestines, which leads to pale stools,' Simeone explained.
'It can also cause itching because the bile acids that are not being excreted normally accumulate in the skin and stimulate nerve endings.'
Stomach pain can be felt from a tumor obstructing the bile duct.
Jaundice can signal pancreatic cancer — and what else?
Elevated levels of bilirubin often indicate liver troubles. Hepatitis (inflammation of the liver), cirrhosis (scarring of the liver) and liver cancer can be culprits.
4 Jaundice can indicate problems with the liver. Here, a doctor shows the anatomy of the liver to a patient.
Peakstock – stock.adobe.com
Other suspects include gallstones in the bile duct, certain blood disorders, viral or bacterial infections, some medications and genetic conditions. Newborns can experience jaundice because their liver isn't fully developed.
With pancreatic cancer, jaundice is a common symptom when the tumor is in the head of the pancreas, blocking the common bile duct.
How is pancreatic cancer diagnosed?
Advertisement
Pancreatic cancer screening is generally recommended for those with a family history of the disease, genetic mutations linked to a higher risk and pancreatic conditions like chronic pancreatitis.
MRIs, CT scans and endoscopic ultrasounds visualize the pancreas and surrounding areas to see if there's a tumor.
If one is detected, a tissue or cell sample is taken to determine if it's cancerous and, if so, the stage of the cancer.
'There are certain blood tests that help in the diagnosis, such as liver function tests, complete blood counts and tumor markers like CA 19-9,' Simeone said, referring to Cancer Antigen 19-9, a protein that can be released by pancreatic cancer cells into the bloodstream.
Advertisement
'The mission of PRECEDE is to help identify an early detection biomarker, such as a blood test that can discover the cancer at the earliest possible stage.'
4 Surgeons operate on a pancreatic cancer patient in France on June 7, 2019. Surgery is one of the potential treatment options for the disease.
AFP via Getty Images
Simeone is the founding director of the Pancreatic Cancer Early Detection (PRECEDE) Consortium, which is studying over 9,500 high-risk individuals to improve early detection of pancreatic cancer.
The goal is to increase the five-year survival rate from 13% to 50% through collaborative research, standardization of screening protocols and development of early detection tools.
How is pancreatic cancer treated?
Advertisement
Depending on when the cancer is caught, treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy and palliative care.
'Surgical resection [to remove the tumor] is typically only an effective option before the cancer has spread,' Simeone said.
'This is precisely why early detection is so important and PRECEDE's primary mission and focus.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
5 minutes ago
- Boston Globe
Lucian Leape, whose work spurred patient safety in medicine, dies at 94
He was chief of pediatric surgery at Tufts University in the 1980s when he noticed frequent mistakes leading to significant patient harm, even death. In a bold move late in his career, Dr. Leape left his full-time surgical practice and began collaborating with colleagues at Harvard University on a study that chronicled for the first time the number of injuries and deaths that resulted from medical error. Known as the Harvard Medical Practice Study, it examined a large population of injured patients in New York state. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up That study led to a landmark report, 'To Err Is Human: Building a Safer Health System,' published in 1999 by the Institute of Medicine (now the National Academy of Medicine). Advertisement In the report, Dr. Leape and his co-authors estimated that 44,000 to 98,000 Americans died each year from medical errors, a majority of which arose from dysfunctional systems -- not flawed individuals, as the medical profession and public had long believed. The idea of systemic error, though widely accepted in industries such as aviation and nuclear power, was an unfamiliar concept in medicine, and it rubbed against the grain of the dominant medical culture of individual accountability, as well as the malpractice system's tradition of seeking a culpable clinician. Advertisement The report, however, galvanized health care regulators and accreditors to enact tighter standards for hospitals, limit work hours by medical residents, and require public reporting of serious errors. As a result of regulations and public pressure, health care systems around the country began to tackle medical mistakes as a system-level problem, launching patient safety departments and hiring patient safety officers. 'He did more than make some critical insights,' Dr. Atul Gawande, a prominent surgeon and author who was assistant administrator for global health at the US Agency for International Development in the Biden administration, said in a 2023 interview for this obituary. 'He took on the entire medical profession.' Lucian L. Leape (he had no middle name, though the 'L' was included on his birth certificate) was born Nov. 7, 1930, in Bellevue, Pa. His father, Lucian Leroy Leape, was a purchasing agent for a small steel company. His mother, Mildred Grace (West) Leape, was a schoolteacher who later taught piano. After receiving his undergraduate degree in chemistry from Cornell University in 1952, he served as a lieutenant in the Navy, and in 1955 entered Harvard Medical School. He met Martha Kinne Palmer in 1951, when both were undergraduates at Cornell, and they married in 1954. Martha Leape, who held master's degrees in guidance counseling and psychology, became a premedical adviser at Harvard University and later ran the university's office of career services. She died this year. In addition to his son James, Dr. Leape leaves two other sons, Jonathan and Gerald, and seven grandchildren. Advertisement After receiving his medical degree in 1959, Dr. Leape trained as a pediatric surgeon at Massachusetts General Hospital and Children's Hospital in Boston. In 1973, he became professor of surgery at Tufts University School of Medicine and chief of pediatric surgery at Tufts-New England Medical Center (now Tufts Medical Center). 'Children are the world's best patients,' he said in an interview for this obituary in 2015. 'They're honest, and they don't have an overlay of neuroses.' In 1986, at age 56, Dr. Leape grew interested in health policy and spent a year at the Rand Corp. on a midcareer fellowship studying epidemiology, statistics, and health policy. Following his stint at Rand, he joined the team at Harvard conducting the Medical Practice Study. When Dr. Howard Hiatt, then the dean of the Harvard School of Public Health (now the Harvard T.H. Chan School of Public Health), offered Dr. Leape the opportunity to work on the study, 'I accepted,' Dr. Leape wrote in his 2021 book, 'Making Healthcare Safe: The Story of the Patient Safety Movement,' 'not suspecting it would change my life.' The most significant finding, he said in the 2015 interview, was that two-thirds of the injuries to patients were caused by errors that appeared to be preventable. 'The implications were profound,' he said. In 1994, he submitted a paper to The New England Journal of Medicine, laying out the extent to which preventable medical injury occurred and arguing for a shift of focus away from individuals and toward systems. But the paper was rejected. 'I was told it didn't meet their standards,' he recalled. Dr. Leape sent the paper out again, this time to The Journal of the American Medical Association. Dr. George Lundberg, then the editor of JAMA, immediately recognized the importance of the topic, Dr. Leape said. 'But he also knew it could offend many doctors. We didn't talk about mistakes.' Advertisement Dr. Donald M. Berwick, president emeritus at the Institute for Healthcare Improvement in Boston and a longtime colleague of Dr. Leape's, agreed. 'To talk about error in medicine back then was considered rude,' he said in an interview in 2020. 'Errors were what we call normalized. Bad things happen, and that's just the way it is. 'But then you had Lucian,' he added, 'this quite different voice in the room saying, 'No, this isn't normal. And we can do something about it.'' Dr. Leape's paper, 'Error in Medicine,' was the first major article on the topic in the general medical literature. The timing of publication, just before Christmas in 1994, Dr. Leape wrote in his 2021 book, was intentional. Lundberg knew it would receive little attention and therefore wouldn't upset colleagues. On Dec. 3, 1994, however, three weeks before the JAMA piece appeared, Betsy Lehman, a 39-year-old health care reporter for The Boston Globe, died after mistakenly receiving a fatal overdose of chemotherapy at the Dana-Farber Cancer Institute in Boston. 'Betsy's death was a watershed event,' Dr. Leape said in a 2020 interview for a short documentary about Lehman. The case drew national attention. An investigation into the death revealed that it wasn't caused by one individual clinician, but by a series of errors involving multiple physicians and nurses who had misinterpreted a four-day regimen as a single dose, administering quadruple the prescribed amount. The case made Dr. Leape's point with tragic clarity: Lehman's death, like so many others, resulted from a system that lacked sufficient safeguards to prevent the error. Advertisement The report 'To Err is Human' was released in 1999, noting that the 44,000 to 98,000 annual deaths from medical mistakes were the equivalent of a jumbo jet crashing every day. That alarming comparison drew significant media attention, and the report led to substantial new federal funding to address the problem of medical errors, along with efforts to educate providers and administrators about the new systems approach to errors. 'There might have developed a patient safety movement in health care without Lucian, but he made it happen years before it otherwise would have,' Berwick said. 'He was probably the first pedigreed specialist from the mainstream of health care to give this problem a name.' Gawande said he believed it was the confidence Dr. Leape had acquired as a surgeon that girded him in the face of strong resistance from colleagues. 'He had enough arrogance to believe in himself and in what he was saying,' Gawande said. 'He knew he was onto something important, and that he could bring the profession along, partly by goading the profession as much as anything.' In 2007, the National Patient Safety Foundation, which Dr. Leape had helped found in 1997 to support the growth of the nascent field, created a patient safety think tank, the Lucian Leape Institute, which is now part of the Institute for Healthcare Improvement. This article originally appeared in
Fox News
an hour ago
- Fox News
Plastic water bottle left in a hot car? Think twice before sipping from it
It's the height of summer, and for many Americans, that means scorching cars and forgotten plastic water bottles rolling around under the seats. But before you take a sip out of one of those, you might want to think twice, experts say. High temperatures and prolonged sun exposure can create conditions that lead to both chemical leaching from plastic bottles and bacterial growth, especially if the bottle has already been opened. Experts warn this dual threat could pose a risk to your health. "The combination of microbial growth and chemical leaching from the plastic makes it a double-edged sword," said Dr. Paul Savage, a toxin expert and chief medical officer at MDLifespan in Chicago. Many single-use plastic water bottles are made from a type of plastic called polyethylene terephthalate (PET). When PET-containing bottles sit in the heat, the polymer chains in the plastic can start to break down and cause the release of various chemicals, including trace amounts of phenol, like bisphenol A (BPA) and phthalates, into the water. "Phenols and phthalates are endocrine disruptors, meaning they interfere with the natural hormones in our body," said Nicole Deziel, an environmental epidemiologist at the Yale School of Public Health. Although the U.S. Food and Drug Administration (FDA) has stated that the current levels of BPA and phthalates used in food packaging are safe, many of these substances have already been banned or voluntarily phased out. "While many of these bacteria are harmless in small amounts, heat can amplify their growth, potentially leading to harmful levels …" Plastics can start leaching chemicals when temperatures reach 85 degrees. And the process accelerates significantly at higher temperatures, especially above 100 degrees, Savage said. Even BPA-free bottles may not be a safer alternative. Many of these products use chemical substitutes that, according to Savage, are structurally similar to BPA and may have similar endocrine-disrupting effects. These alternatives haven't been studied extensively, leaving scientists cautious. Another growing concern is the presence of microplastics – tiny plastic particles that can shed from the bottle over time, especially under heat. Studies in animals have linked microplastic exposure to inflammation, cellular stress and hormonal disruption, though the full impact on human health remains unclear. Plastic bottles reused after opening – especially those left in warm environments – can also become a breeding ground for bacteria, including E. coli and Staphylococcus aureus (staph infection), introduced from the mouth, hands or air. "While many of these bacteria are harmless in small amounts, heat can amplify their growth, potentially leading to harmful levels that cause gastrointestinal issues or infections," Savage told Fox News Digital. Bacteria can thrive in microscopic grooves and scratches in plastic bottles, Savage said. Studies have found that bacteria can grow in open bottles within 48 hours, even at room temperature. Some concerns about heated plastic bottles have been exaggerated or misunderstood. For example, claims that dioxins – known carcinogens – are released when plastic bottles are left in hot cars have been debunked by scientists. These rumors trace back in part to a viral 2006 email attributed to musician Sheryl Crow, a breast cancer survivor, who warned about cancer-causing chemicals from heated bottles. However, experts affirm that PET does not contain or produce dioxins. To reduce exposure to potentially harmful chemicals and microbes, experts recommend avoiding the reuse of single-use plastic water bottles – especially in hot environments. "Glass and stainless steel can withstand repeated heat and sun exposure," said Bryan Quoc Le, a California food scientist and author of the book "150 Food Science Questions Answered." While bacteria can also grow in reusable containers, glass and stainless steel bottles are easier to clean thoroughly and can withstand high-temperature washing — "which can reduce microbial growth," Le added.
CNN
an hour ago
- CNN
China fights mosquito-borne chikungunya virus with drones, fines and nets as thousands fall ill
Chinese authorities are using nets, spraying insecticide and even deploying drones to fight the mosquito-borne chikungunya virus, which has infected thousands of people. Authorities had reported more than 7,000 cases of the virus as of Wednesday, mostly in the southern Chinese manufacturing hub of Foshan, some 170 kilometers (105 miles) from Hong Kong. The number of new cases appears to be dropping slowly, according to authorities. It appears to be the largest chikungunya outbreak ever documented in China, according to Cesar Lopez-Camacho of the University of Oxford. The virus is transmitted by infected mosquitoes and can cause fever and joint pain. 'What makes this event notable is that chikungunya has never been established in mainland China before,' Lopez-Camacho said in a statement. 'This suggests that most of the population had no preexisting immunity, making it easier for the virus to spread quickly.' Chinese state television has shown workers spraying insecticide around city streets, residential areas, construction sites and other areas where people may come into contact with mosquitoes. Workers sprayed some places before entering office buildings. Unusually heavy rains and high temperatures have worsened the crisis in China, and authorities are using drones to try to find standing water, where mosquitoes lay eggs. Authorities also have threatened to fine people who don't empty water from outdoor receptacles. Residents can be subject to fines of up to 10,000 yuan ($1,400) and have their electricity cut off. Because of the virus, the US has issued a travel advisory suggesting that Americans take extra precautions when visiting China's Guangdong province, where Foshan is located, as well as Bolivia and some island nations in the Indian Ocean. Since the 2003 SARS outbreak, China has used strict measures to fight the spread of viruses, including hard-line tactics during the COVID-19 pandemic. This time, patients are being forced to stay in hospital in Foshan for at least one week and authorities briefly enforced a two-week home quarantine, which was dropped because the disease cannot be transmitted between people. Reports also have emerged of attempts to stop the spread of chikungunya with fish that eat mosquito larvae and even larger mosquitoes to eat the insects carrying the virus. Officials have held meetings and adopted protocols at the national level in a sign of China's determination to eliminate the outbreak and avoid public and international criticism.
